Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 19020907)

1.

LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.

Gorostidi A, Ruiz-Martínez J, Lopez de Munain A, Alzualde A, Martí Massó JF.

Neurogenetics. 2009 Apr;10(2):157-9. doi: 10.1007/s10048-008-0162-0. Epub 2008 Nov 20.

PMID:
19020907
2.

Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease.

Spitz M, Pereira JS, Nicareta DH, Abreu Gde M, Bastos EF, Seixas TL, Pimentel MM.

Parkinsonism Relat Disord. 2015 Jul;21(7):825-6. doi: 10.1016/j.parkreldis.2015.03.029. Epub 2015 May 2. No abstract available.

PMID:
25952961
3.

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.

Somme JH, Molano Salazar A, Gonzalez A, Tijero B, Berganzo K, Lezcano E, Fernandez Martinez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 May;21(5):494-9. doi: 10.1016/j.parkreldis.2015.02.019. Epub 2015 Mar 2.

PMID:
25840672
4.

Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.

Helmich RC, Thaler A, van Nuenen BF, Gurevich T, Mirelman A, Marder KS, Bressman S, Orr-Urtreger A, Giladi N, Bloem BR, Toni I; LRRK2 Ashkenazi Jewish Consortium.

Neurology. 2015 Jan 27;84(4):399-406. doi: 10.1212/WNL.0000000000001189. Epub 2014 Dec 24.

PMID:
25540317
5.

Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J.

Neurobiol Aging. 2015 Feb;36(2):1105-9. doi: 10.1016/j.neurobiolaging.2014.10.039. Epub 2014 Nov 5.

PMID:
25475535
6.

Parkinson's disease, genetic variability and the Faroe Islands.

Petersen MS, Guella I, Bech S, Gustavsson E, Farrer MJ.

Parkinsonism Relat Disord. 2015 Jan;21(1):75-8. doi: 10.1016/j.parkreldis.2014.10.027. Epub 2014 Nov 4.

PMID:
25466404
7.

Neurogenetic disorders in the Basque population.

Martí Massó JF, Zarranz JJ, Otaegui D, López de Munain A.

Ann Hum Genet. 2015 Jan;79(1):57-75. doi: 10.1111/ahg.12088. Epub 2014 Dec 1. Review.

PMID:
25440984
8.

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K; LRRK2 Ashkenazi Jewish Consortium.

Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. doi: 10.1016/j.parkreldis.2014.09.033. Epub 2014 Nov 20.

PMID:
25434972
9.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.

PMID:
25401981
10.

Commentary on "Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice".

Popugaeva E, Bezprozvanny I.

Front Cell Neurosci. 2014 Oct 28;8:351. doi: 10.3389/fncel.2014.00351. eCollection 2014. No abstract available.

11.

Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease.

Gaig C, Vilas D, Infante J, Sierra M, García-Gorostiaga I, Buongiorno M, Ezquerra M, Martí MJ, Valldeoriola F, Aguilar M, Calopa M, Hernandez-Vara J, Tolosa E.

PLoS One. 2014 Oct 17;9(10):e108982. doi: 10.1371/journal.pone.0108982. eCollection 2014.

12.

The role of geographic context on mental health: lessons from the implementation of mental health atlases in the Basque Country (Spain).

Iruin-Sanz A, Pereira-Rodríguez C, Nuño-Solinís R.

Epidemiol Psychiatr Sci. 2015 Feb;24(1):42-4. doi: 10.1017/S2045796014000596. Epub 2014 Oct 13. No abstract available.

PMID:
25308285
13.

Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers.

Caesar M, Felk S, Aasly JO, Gillardon F.

Neuroscience. 2015 Jan 22;284:311-24. doi: 10.1016/j.neuroscience.2014.09.070. Epub 2014 Oct 6.

PMID:
25301747
14.

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL, Stucky CL, Kanthasamy AG, Kalyanaraman B.

Neurosci Lett. 2014 Nov 7;583:159-64. doi: 10.1016/j.neulet.2014.09.042. Epub 2014 Sep 26.

PMID:
25263790
15.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.

PMID:
25127457
16.

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Hatano T, Funayama M, Kubo S, Mata IF, Oji Y, Mori A, Zabetian CP, Waldherr SM, Yoshino H, Oyama G, Shimo Y, Fujimoto K, Oshima H, Kunii Y, Yabe H, Mizuno Y, Hattori N.

Neurobiol Aging. 2014 Nov;35(11):2656.e17-23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2.

PMID:
24973808
17.

Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson's disease.

Chien HF, Figueiredo TR, Hollaender MA, Tofoli F, Takada LT, Pereira Lda V, Barbosa ER.

Arq Neuropsiquiatr. 2014 May;72(5):356-9.

18.

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, Zini M, Zecchinelli AL, Asselta R, Duga S, Paganoni AM, Pezzoli G, Seia M, Goldwurm S.

Parkinsonism Relat Disord. 2014 Aug;20(8):911-4. doi: 10.1016/j.parkreldis.2014.04.016. Epub 2014 Apr 25.

19.

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.

Botta-Orfila T, Morató X, Compta Y, Lozano JJ, Falgàs N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernández M, Molinuevo JL, Antonell A, Martí MJ, Fernández-Santiago R, Ezquerra M.

J Neurosci Res. 2014 Aug;92(8):1071-7. doi: 10.1002/jnr.23377. Epub 2014 Mar 20.

PMID:
24648008
20.

Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.

De Rosa A, De Michele G, Guacci A, Carbone R, Lieto M, Peluso S, Picillo M, Barone P, Salemi F, Laiso A, Saccà F, Tessitore A, Pellecchia MT, Bonifati V, Criscuolo C.

J Parkinsons Dis. 2014;4(1):123-8. doi: 10.3233/JPD-130312.

PMID:
24496098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk